Parenteral Nutrition Support for Patients With Pancreatic Cancer
Primary Purpose
Cancer Cachexia, Pancreatic Cancer
Status
Completed
Phase
Phase 2
Locations
Germany
Study Type
Interventional
Intervention
parenteral nutrition
Sponsored by
About this trial
This is an interventional supportive care trial for Cancer Cachexia focused on measuring parenteral nutrition, cancer cachexia, pancreatic cancer
Eligibility Criteria
Inclusion Criteria:
- histological proved pancreatic cancer
- progressive cancer cachexia
- refractive to enteral supplementation
- informed consent
Exclusion Criteria:
- prefinal status
- septic disease
Sites / Locations
- Universitätsmedizin Berlin - Charité
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
parenteral nutrition
Arm Description
25kcal/kg/bw /day via parenteral support
Outcomes
Primary Outcome Measures
nutritional status presented by phase angle
Secondary Outcome Measures
quantity of port infections, quantity of oedema, quantity of diarrhea
Full Information
NCT ID
NCT00919659
First Posted
June 9, 2009
Last Updated
June 11, 2009
Sponsor
CONKO-Studiengruppe
Collaborators
Fresenius AG
1. Study Identification
Unique Protocol Identification Number
NCT00919659
Brief Title
Parenteral Nutrition Support for Patients With Pancreatic Cancer
Official Title
Parenteral Nutrition Support for Patients With Pancreatic Cancer. A Phase II Study.
Study Type
Interventional
2. Study Status
Record Verification Date
June 2009
Overall Recruitment Status
Completed
Study Start Date
January 2002 (undefined)
Primary Completion Date
January 2004 (Actual)
Study Completion Date
May 2004 (Actual)
3. Sponsor/Collaborators
Name of the Sponsor
CONKO-Studiengruppe
Collaborators
Fresenius AG
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study is to determine whether the additional nutrition support is improving the nutritional status of patients suffering cancer caxechia or not.
Detailed Description
To examine the impact of additional parenteral nutrition (APN) we prospective evaluated 32 pts suffering APC and progressive cachexia. This assay is based on a bioelectrical impedance analysis (BIA) as a proven tool for nutritional investigation in patients with chronic disease. Phase angle, determined by BIA, has been found to be a prognostic indicator in several chronic and malignant conditions, such as HIV, liver cirrhosis, chronic obstructive pulmonary disease lung cancer and pancreatic cancer.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cancer Cachexia, Pancreatic Cancer
Keywords
parenteral nutrition, cancer cachexia, pancreatic cancer
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Phase 2
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
32 (Actual)
8. Arms, Groups, and Interventions
Arm Title
parenteral nutrition
Arm Type
Experimental
Arm Description
25kcal/kg/bw /day via parenteral support
Intervention Type
Dietary Supplement
Intervention Name(s)
parenteral nutrition
Other Intervention Name(s)
no specific brand name
Intervention Description
25kcal/kg bw with parenteral nutrition
Primary Outcome Measure Information:
Title
nutritional status presented by phase angle
Time Frame
12 weeks
Secondary Outcome Measure Information:
Title
quantity of port infections, quantity of oedema, quantity of diarrhea
Time Frame
12 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
histological proved pancreatic cancer
progressive cancer cachexia
refractive to enteral supplementation
informed consent
Exclusion Criteria:
prefinal status
septic disease
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
helmut oettle, MD
Organizational Affiliation
CONKO-Studiengruppe
Official's Role
Principal Investigator
Facility Information:
Facility Name
Universitätsmedizin Berlin - Charité
City
Berlin
ZIP/Postal Code
13353
Country
Germany
12. IPD Sharing Statement
Citations:
PubMed Identifier
20214798
Citation
Pelzer U, Arnold D, Govercin M, Stieler J, Doerken B, Riess H, Oettle H. Parenteral nutrition support for patients with pancreatic cancer. Results of a phase II study. BMC Cancer. 2010 Mar 9;10:86. doi: 10.1186/1471-2407-10-86.
Results Reference
derived
Learn more about this trial
Parenteral Nutrition Support for Patients With Pancreatic Cancer
We'll reach out to this number within 24 hrs